Roivant Sciences Stock Number Of Shares Shorted
Roivant Sciences fundamentals help investors to digest information that contributes to Roivant Sciences' financial success or failures. It also enables traders to predict the movement of Roivant Stock. The fundamental analysis module provides a way to measure Roivant Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Roivant Sciences stock.
Roivant |
Roivant Sciences Company Number Of Shares Shorted Analysis
Roivant Sciences' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Roivant Sciences Number Of Shares Shorted | 215.84 K |
Most of Roivant Sciences' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Roivant Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
CompetitionBased on the recorded statements, Roivant Sciences has 215.84 K of outstending shares currently sold short by investors. This is 93.25% lower than that of the Biotechnology sector and 95.77% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 95.41% higher than that of the company.
Roivant Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Roivant Sciences' direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Roivant Sciences could also be used in its relative valuation, which is a method of valuing Roivant Sciences by comparing valuation metrics of similar companies.Roivant Sciences is currently under evaluation in number of shares shorted category among its peers.
Roivant Fundamentals
Operating Margin | (37.08) % | |||
Number Of Shares Shorted | 215.84 K | |||
Revenue | 61.28 M | |||
EBITDA | (1.11 B) | |||
Net Income | (1.12 B) | |||
Cash And Equivalents | 2 B | |||
Cash Per Share | 8.97 X | |||
Total Debt | 481.4 M | |||
Debt To Equity | 0.13 % | |||
Current Ratio | 9.84 X | |||
Book Value Per Share | 7.74 X | |||
Cash Flow From Operations | (843.39 M) | |||
Earnings Per Share | (4.09) X | |||
Number Of Employees | 620 | |||
Total Asset | 2.39 B | |||
Retained Earnings | (3.77 B) | |||
Working Capital | 1.53 B | |||
Z Score | -2.95 | |||
Net Asset | 2.39 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.ZLAB | Zai Lab | |
ASLE | AerSale Corp | |
ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Roivant Stock
If you are still planning to invest in Roivant Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Roivant Sciences' history and understand the potential risks before investing.
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |